People suffering from chronic conditions such as autoimmune diseases, chronic fatigue syndrome, and fibromyalgia may find relief through peptide therapy
Am J Resp Critical Care Medicine, 2017
BPC-157 is a research-stage peptide without extensive human clinical trials
Targeted probiotic and postbiotic strainsincluding Akkermansia muciniphila, clinically studied Lactobacillus strains, and the postbiotic HTBPL-1help optimize gut flora balance, support insulin sensitivity, and promote feelings of fullness after eating
Every batch is independently tested by third-party laboratories
It also calms inflammation and oxidative stress, supporting barrier repair and faster healing after procedures or environmental insults